Welcome to the Advanced Practice Providers Oncology Summit, the CE conference devoted to providing the latest developments in the multidisciplinary treatment, practical patient management, and interprofessional care of oncology patients.
Participate in this two-day program presenting the latest clinical and practical strategies to improve care for your oncology patients and communication within your healthcare team.
Who Should AttendClinicians who are serious about improving care for their oncology patients.
> Nurse Practitioners
> Physician Assistants
> Pharmacists
> Oncology Nurse Specialists
> Others involved in the care of oncology patients
The APP Oncology Summit is a two-day conference designed to provide advanced practice providers (APPs) with the latest evidenced-based strategies to optimize care and outcomes for patients with cancer. This conference is planned with and for advanced practice providers (NPs, PAs, pharmacists, and nurse specialists) and is a collaborative effort of oncology clinicians from multiple organizations in each community.
The APP Oncology Summit offers a unique opportunity for APPs from various healthcare teams in the community to collaborate, learn from each other and national faculty, and share best practices on a range of issues related to the care of cancer patients.
The Community Oncology Alliance (COA) is a non-profit organization dedicated to advocating for community oncology practices and, most importantly, the patients they serve. COA is the only organization dedicated solely to community oncology where the majority of Americans with cancer are treated. The mission of COA is to ensure that cancer patients receive quality, affordable, and accessible cancer care in their own communities.
COA represents all the diverse members of the cancer care system. As the only organization dedicated solely to representing, supporting, and recognizing community oncology, COA is truly the voice of community oncology.
COA is proud to count individuals from all levels of the cancer care delivery system as members, including oncologists, hematologists, pharmacists, mid-level providers, oncology nurses, patients, survivors, industry representatives, and even oncology fellows.
In the span of just one year, the US Food and Drug Administration (FDA) approved 13 new therapies for more than 16 types of cancer. The number of new approvals and new indications will continue to grow each year. Be sure not to miss this timely update on the most recent advances in cancer therapies.
ASCO named adoptive cell immunotherapy as the clinical cancer Advance of the Year in 2018. By genetically re-engineering a patient’s own immune T cells, CAR-T cells are custom made to work against the cancer in an individual patient. The 2018 Nobel Prize in medicine was awarded for this key cancer breakthrough. APPs who want to be on the cutting edge of cancer care will not want to miss learning more about the T-cell harvesting process, the overall patient experience and how to safely manage the potential toxicities associated with CAR-T cell therapy.
All clinicians who care for seriously ill patients should understand the domains of primary palliative care and be encouraged to use these skills to provide high-quality disease management and symptom palliation to all seriously ill patients. Come to this session to learn strategies for assessing and addressing the palliative care needs of your patients. It may be as simple as asking the right questions.
View all session topics in each unique agenda by selecting a location below.
9123 SE St. Helens St. Suite 280
Clackamas, OR 97015
Phone: (503) 659-5558
Fax: (503) 716-3883
info@horizoncme.com